LESLIE STANALAND: Open Payments
NPI 1871929364 · THOMASVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$658 in 28 payments from 11 companies in 2025. Trend: 2023 $558 · 2024 $822 · 2025 $658
Food & beverage: $658
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $242 |
| ABIOMED | 2 | $160 |
| PFIZER INC. | 4 | $56 |
| E.R. Squibb & Sons, L.L.C. | 3 | $48 |
| Abbott Laboratories | 1 | $31 |
| Amgen Inc. | 2 | $28 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $17 |
Products named: LEQVIO, VYNDAQEL, JOT DX, CAMZYOS, REPATHA, ENTRESTO, WAINUA, LifeVest.
Industry payments across GA — which companies pay providers there.
